In line with the broad spectrum of mRNA expression observed in primary DLBCL patient samples (Fig 3A), we detected a broad spectrum of SLF2 protein levels in patient‐derived DLBCL cell lines (Fig 4B). Here, SLF2 is linked to diffuse large B-cell lymphoma.